Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.5M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
4.95M
-
Shares change
-
-1.56M
-
Total reported value, excl. options
-
$23.5M
-
Value change
-
-$8.9M
-
Put/Call ratio
-
0.1
-
Number of buys
-
19
-
Number of sells
-
-37
-
Price
-
$4.75
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q2 2022
70 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q2 2022.
AVITA Medical, Inc. - Common Stock (RCEL) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.95M shares
of 26.5M outstanding shares and own 18.68% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.15M shares), PURA VIDA INVESTMENTS, LLC (742K shares), FARALLON CAPITAL MANAGEMENT LLC (580K shares), BlackRock Inc. (477K shares), RENAISSANCE TECHNOLOGIES LLC (327K shares), MILLENNIUM MANAGEMENT LLC (267K shares), GEODE CAPITAL MANAGEMENT, LLC (250K shares), AMERIPRISE FINANCIAL INC (154K shares), RTW INVESTMENTS, LP (107K shares), and Ergoteles LLC (102K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.